Ireland's Perrigo Q2 profit beats on portfolio streamlining

Perrigo

05/08/2026 11:46

Overview
Ireland consumer self-care firm's Q2 revenue slightly beat analyst expectations
Adjusted EPS for Q2 beat consensus despite year-over-year decline
Company reaffirmed 2026 outlook and completed Dermacosmetics divestiture

Outlook
Perrigo reaffirms 2026 adjusted EPS guidance of $2.00 to $2.30 All In, $2.25 to $2.55 Core
Company expects 2026 Core organic net sales growth of (3.5)% to +0.5%
Perrigo anticipates sequentially stronger second-half 2026 performance driven by cost savings and growth initiatives

Result Drivers
CATEGORY SOFTNESS - Co said ongoing softness in consumption and lower retail inventory levels weighed on net sales and margins
MARKET SHARE GAINS - Innovation and commercial execution drove market share gains across key categories, per interim CEO Albert Manzone
PORTFOLIO STREAMLINING - Completion of Dermacosmetics divestiture contributed to reported EPS and reduced debt

Company press release: ID:nPn9P9mbza

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Slight Beat*
$1.02 bln
$1.01 bln (3 Analysts)
Q2 Adjusted EPS
Beat
$0.50
$0.34 (3 Analysts)
Q2 EPS
 
$0.63
 
Q2 Adjusted Gross Margin
 
35.60%
 
*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for Perrigo Company PLC is $15.50, about 43.8% above its August 4 closing price of $10.78
The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 5 three months ago

Reuters Recommended Reads
Aug 5 - Edgewell Personal Care Q3 sales miss estimates; narrows FY outlook
Aug 3 - Clorox Q4 revenue and adjusted EPS beat expectations despite sales drop
Aug 3 - Germany's Beiersdorf H1 sales fall, trims FY outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)